Nine Masts Capital LTD Abb Vie Inc. Transaction History
Nine Masts Capital LTD
- $335 Million
- Q1 2025
A detailed history of Nine Masts Capital LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Nine Masts Capital LTD holds 40,000 shares of ABBV stock, worth $7.36 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$7.36 Million% of portfolio
0.17%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ABBV
# of Institutions
4,255Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.7 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.1 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.57 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $325B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...